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The mechanisms dictating whether a cell pro-
liferates or differentiates have undergone intense
scrutiny, but they remain poorly understood. Here,
we report that UPF1, a central component in the
nonsense-mediated RNA decay (NMD) pathway,
plays a key role in this decision by promoting the
proliferative, undifferentiated cell state. UPF1 acts,
in part, by destabilizing the NMD substrate encoding
the TGF-b inhibitor SMAD7 and stimulating TGF-b
signaling. UPF1 also promotes the decay of mRNAs
encoding many other proteins that oppose the pro-
liferative, undifferentiated cell state. Neural differen-
tiation is triggered when NMD is downregulated
by neurally expressed microRNAs (miRNAs). This
UPF1-miRNA circuitry is highly conserved and
harbors negative feedback loops that act as a
molecular switch. Our results suggest that the
NMD pathway collaborates with the TGF-b signaling
pathway to lock in the stem-like state, a cellular
state that is stably reversed when neural differentia-
tion signals that induce NMD-repressive miRNAs are
received.
INTRODUCTION
The identity of the underlying mechanisms dictating whether a
cell proliferates or differentiates has been one of the most impor-
tant questions in the field of biology for the past several decades.
In contrast to the plethora of knowledge about transcriptional
mechanisms that control such proliferation versus differentiation
decisions, very little is known about the role of posttranscrip-
tional mechanisms in this process. Recent studies have identi-
fied specific RNA-binding proteins and microRNAs (miRNAs)
that can swing the balance in one direction or another, but the
mechanisms underlying these pathways remain poorly under-
stood (Melton and Blelloch, 2010).748 Cell Reports 6, 748–764, February 27, 2014 ª2014 The AuthorsIn this communication, we report that the nonsense-mediated
RNA decay (NMD) pathway plays a crucial role in this decision.
NMD is a conserved RNA degradation mechanism that depends
on several proteins, including UPF1, an RNA helicase with
ATPase activity that is absolutely essential for NMD, and the
adaptor proteins, UPF2 and UPF3B, that are required for specific
branches of NMD (Popp and Maquat, 2013; Schweingruber
et al., 2013). NMD was originally identified as a quality control
pathway that rapidly degrades aberrant transcripts harboring
premature stop (nonsense) codons (PTCs) (Chang et al., 2007).
Recent studies have shown that NMD is not only a quality control
pathway but also a regulatory pathway that controls normal gene
expression. Gene expression-profiling studies have shown that
either loss or depletion of NMD factors in species scaling the
phylogenetic scale leads to the dysregulation of 3%–15% of
normal transcripts (Schweingruber et al., 2013). Although many
of these dysregulated mRNAs are probably indirectly regulated
by NMD, studies have begun to identify some of them as direct
NMD targets (Hurt et al., 2013; Kim et al., 2012; Tani et al.,
2013). One of the ‘‘NMD-inducing features’’ in these direct
NMD substrates is the presence one or more introns down-
stream of the stop codon that defines the end of the open
reading frame (ORF) encoding the protein (Chang et al., 2007).
Intron splicing leads to deposition of a set of proteins called
the exon-junction complex (EJC), which interacts with UPF1
and other NMD factors recruited at the site of translation termi-
nation, ultimately leading to rapid mRNA decay. Evidence sug-
gests that mRNAs harboring a stop codon in the final exon avoid
rapid mRNA decay because actively translating ribosomes strip
off EJCs before encountering the stop codon during the pioneer
round of translation (Dostie and Dreyfuss, 2002; Chang et al.,
2007). Other NMD-inducing features are upstream ORFs
(uORFs) and long 30 UTRs, which trigger NMD by mechanisms
that are not clearly understood (Schweingruber et al., 2013).
The finding that NMD regulates the levels of many normal
mRNAs raises the possibility that NMD regulates normal biolog-
ical events. In support of this possibility, studies conducted in a
wide range of organisms have shown that loss or depletion of
NMD factors causes specific developmental defects (Vicente-
Crespo and Palacios, 2010). Although these studies have clearly
shown that NMD factors have roles in various biological pro-
cesses, it has not been determined whether this is because of
NMD’s ability to regulate normal gene expression programs
(i.e., through decay of subsets of normal mRNAs) or its quality
control function (i.e., through decay of aberrant transcripts).
The notion that NMD’s ability to regulate normal gene expres-
sion programs is physiologically important is supported by the
growing evidence that NMD itself is subject to regulation (Huang
and Wilkinson, 2012; Karam et al., 2013). Our laboratory
recently reported that the neurally expressed miRNAs miR-
128-1 and miR-128-2 repress NMD through direct silencing of
UPF1 and the EJC core protein MLN51 (Bruno et al., 2011).
Although we did not address the physiological relevance of
this regulation, we obtained several lines of evidence sug-
gesting that these two miRNAs (which are identical, and thus,
we will henceforth collectively refer to as ‘‘miR-128’’) are impor-
tant for nervous system development. In the present paper, we
directly address the roles of miR-128 and one of its targets,
UPF1, as well as their regulatory relationship, in controlling the
decision to maintain the undifferentiated cell state or undergo
neural differentiation.
RESULTS
UPF1 Promotes the Stem-like State and Is
Downregulated to Permit Neural Differentiation
Given that UPF1 is a core NMD factor that we previously showed
is a direct target of a neural-promoting miRNA (Bruno et al.,
2011), we examined whether UPF1 levels are regulated in the
nervous system. We found that Upf1 mRNA levels decrease
during mouse embryonic brain cortex development and when
mouse neural stem cells (mNSCs) and human neural progenitor
cells are induced to undergo maturation (Figures 1A and S1A).
Upf1 mRNA is also downregulated in differentiated P19 cells
(Figure S1A), which undergoes neural differentiation in response
to retinoic acid (RA) treatment. To assess the generality of this
downregulatory response, we examined other NMD factors
and found that Upf2, Upf3b, Smg1, and Smg6 mRNA were
also downregulated in mNSCs undergoing maturation (Fig-
ure 1A). In contrast, Smg5 and Smg7 mRNA levels were
modestly upregulated in maturing mNSCs.
The downregulation of UPF1 and most other NMD factors that
we tested raised the possibility that the magnitude of NMD itself
is reduced during neural differentiation and maturation. In sup-
port of this, three well-established NMD substrates—Atf3,
Gadd45b, and Gas5 mRNA (Chan et al., 2007; Huang and
Wilkinson, 2012)—were upregulated in differentiating P19 cells
(Figure S1B). To directly assess NMD activity, we used a dual
NMD reporter system (Boelz et al., 2006) and found that the ratio
of PTC/PTC+ transcripts decreased when P19 cells underwent
neural differentiation, indicative of decreased NMD activity (Fig-
ures 1B and S1C). NMD activity was also decreased during
mNSC maturation, as assessed using a tetracycline (tet)-
promoter-based NMD reporter system to directly measure
mRNA half-life (Singh et al., 2008) (Figure 1C).
To determine whether this NMD downregulatory response has
a causal role in neural differentiation, we maintained UPF1 levels
in differentiating P19 cells by expressing modest levels of exog-Cenous UPF1 from a heterologous promoter. We found that this
blocked the upregulation of neural differentiation markers and
largely prevented the downregulation of stem cell markers (Fig-
ures 1D–1F). As further evidence that UPF1 promotes the
stem-like state, we found that UPF1 overexpression was suffi-
cient to upregulate stem cell markers (Figure S1D). To determine
whether repression of UPF1 is sufficient to elicit neural differen-
tiation, we usedRNAi to deplete UPF1 in P19 cells.We found that
UPF1 knockdown was sufficient to elicit the initial stages of
differentiation, as assessed by the upregulation of neural differ-
entiation markers and the downregulation of stem cell markers
(Figures 1G and S1E). UPF1 knockdown also stimulated neural
maturation, as assessed in mNSCs grown under proneural
differentiation conditions (Figure 1H).
Given that UPF1 is an essential factor for another RNA decay
pathway—Staufen 1 (STAU1)-mediated mRNA decay (SMD)
(Gong et al., 2009)—this raised the possibility that the UPF1
downregulatory response promotes neural maturation because
it depresses the SMD pathway. This is unlikely to be the case
because we found that depleting the essential SMD factor
STAU1 did not promote mNSCmaturation, as assessed by early
neural maturation markers (Figure S1F). To assess whether the
ability to repress neural maturation is a general property of
NMD or mediated by UPF1 in particular, we examined the effect
of loss of the NMD factor, UPF3B, which, like UPF1, is downre-
gulated during neural maturation (Figure 1A). We isolated
mNSCs from the Upf3b null mice we recently generated (Huang
and Wilkinson, 2012) and found that when grown under differen-
tiating conditions, these Upf3b null mNSCs had significantly
higher level of early neural markers than littermate control
mNSCs, suggesting that UPF3B normally suppresses the ability
of these cells to differentiate (Figure S1G). Taken together, these
data indicate that the NMD downregulatory response that
occurs during the neural differentiation program is essential for
the normal differentiation and maturation of neural cells.
UPF1 Promotes Proliferation at the G1/S Transition
Our finding that UPF1 represses neural differentiation and
maturation raised the possibility that it does so because UPF1
favors the proliferative state. Indeed, we found that depleting
UPF1 in undifferentiated P19 cells reduced their ability to prolif-
erate (Figure 1I). Conversely, modest overexpression of UPF1
was sufficient to increase their proliferation (Figure 1J). Because
UPF1 is normally downregulated during neural differentiation
(Figures 1A and S1A), this led us to next ask whether this down-
regulatory response is necessary for P19 cells to cease prolifer-
ating in response to a differentiation signal. Indeed, we found
that maintenance of UPF1 levels with an Upf1 expression vector
prevented the cessation of proliferation that normally occurs
when P19 cells are induced to undergo neural differentiation
by RA treatment (Figure 1K).
It is well established that neural differentiation leads to
inhibited cell proliferation at the G1/S transition point of the cell
cycle (Orford and Scadden, 2008). Thus, if the UPF1 downregu-
latory response we uncovered has a role in this cell-cycle
blockade, then UPF1 knockdown ought to inhibit progression
through G1/S. Indeed, we found that depletion of UPF1 caused
an accumulation of cells in G1 and reduced the number of cells inell Reports 6, 748–764, February 27, 2014 ª2014 The Authors 749
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S phase, indicative of a G1/S transition block (Figures 1L and
S1H). As a positive control, we tested the standard neural differ-
entiation signal, RA, and found it had the same effect (Figures 1L
and S1H). Forced UPF1 expression in RA-treated P19 cells
largely reversed the G1/S blockade, providing direct evidence
that UPF1 drives cells to progress through this transition point
of the cell cycle (Figure 1L).
NMD Selectively Degrades mRNAs Encoding
Proliferation Inhibitory Factors
Our finding that the NMD factor, UPF1, promotes progression
through G1/S raised the possibility that NMD promotes the
decay of mRNAs encoding inhibitory proteins that block pro-
gression through this stage of the cell cycle. Ten factors with
well-defined G1/S inhibitory activity are known, most of which
are repressed in stem cells to maintain a high rate of self-renewal
activity and must be activated for such cells to leave the mitotic
cycle and undergo terminal differentiation (Orford and Scadden,
2008). As a first step toward evaluating whether the mRNAs en-
coding any of these G1/S inhibitors are NMD targets, we exam-
ined whether they have known NMD-inducing features, such as
an uORF, a long 30 UTR (>1 kb), an intron in the 30 UTR, or were
alternatively spliced to generate one or more of these features
(see the Introduction). We found that eight of these ten mRNAs
had NMD-inducing features (Table S1). To empirically determine
whether any of these eight mRNAs are regulated by NMD, we
examinedwhether they are upregulated whenNMD is perturbed.
Quantitative RT-PCR (qRT-PCR) analysis demonstrated that
transcripts from four of these genes—p21 (Cdkn1a), p27
(Cdkn1b), p57 (Cdkn1c), and Mapk6 (Erk3)—were significantly
upregulated in UPF1-depleted P19 cells (Figure 2A). Given that
destabilization is the hallmark of direct NMD target mRNAs
(Chang et al., 2007), we performed RNA half-life analysis on
these four mRNAs and found they were stabilized in response
to UPF1 depletion (Figures 2B and S2A). Together with their
increased steady-state level in response to NMD perturbation
and the fact they have NMD-inducing features, this provided
strong evidence that these four transcripts are direct NMD
targets. Further support that p21 mRNA is a direct NMD target
is that it is stabilized when its putative NMD-inducing feature—
an uORF—is deleted (Kim et al., 2012).Figure 1. UPF1 Is Downregulated to Permit Neural Differentiation
(A) qPCR analysis of NMD factor transcript levels in mNSCs incubated in differe
(B andC) NMD activity is decreased during neural differentiation. P19 cells treated
reporters developed by Boelz et al. (2006) (B) and Singh et al. (2008) (C), as desc
(D–F) Rescue of UPF1 expression suppresses neural differentiation (diff.). (D) qPC
with the UPF1 expression vector (Ev-Upf1) or empty vector (Ev-C) and treated with
which were given a value of 1. (E) Western analysis quantification is the mean o
Immunofluorescence analysis is of UPF1 (red), NESTIN (green), and DAPI (blue
Supplemental Experimental Procedures for details). Ctrl, control.
(G andH) Suppression of Upf1 expression is sufficient to induce neural differentiat
(H) mNSCs transfected with either UPF1 siRNA or luciferase (Luc) siRNA (the la
cultured in the absence of RA.
(I–L) The Upf1 downregulatory response is necessary and sufficient to inhibit cel
(I–K) Cell-counting experiments performed in P19 cells treated and transfected a
(L) Cell-cycle analysis of P19 cells treated and transfected as indicated (n = 3). E
Statistical analysis for all figure panels was done using the paired Student’s t test (
noted, all experiments were repeated three times, and error bars depict SEM. Tran
See also Figure S1.
CIf UPF1 stimulates transition through the G1/S phase of the
cell cycle by selectively promoting the decay of mRNAs encod-
ing G1/S proliferation inhibitory factors, this predicts that it
would tend to not target mRNAs encoding G1/S proliferation
activator factors. To test this, we analyzed the mRNAs encod-
ing the eight proteins with well-established roles as direct
activators of G1/S progression (Orford and Scadden, 2008)
(Table S1) and found that none of them was significantly upre-
gulated in response to depletion of UPF1 (Figure 2A). Instead,
the mRNAs encoding five of these factors—CCND1, CCNE,
CDC25A, CDK4, and MYC—were significantly downregulated
when UPF1 was depleted (Figure 2A), consistent with our
finding that UPF1 downregulation triggers reduced cell pro-
liferation (Figures 1I and S1H). We conclude that NMD selec-
tively targets mRNAs encoding G1/S inhibitor proteins, thereby
providing a possible mechanism by which UPF1 promotes
proliferation.
NMD Selectively Degrades mRNAs Encoding Neural
Differentiation Factors
Wepostulated that an additional mechanism by which NMD pro-
motes the undifferentiated cell state is by degrading mRNAs
encoding differentiation factors. We focused our analysis on
neural differentiation factors given that deficiencies in NMD
cause intellectual disability (Tarpey et al., 2007). Only well-estab-
lished neural differentiation factors were selected, including
those acting in neural signaling pathways, transcription factors
that reprogram cells into neurons, and downstream effectors
that have been shown to have essential roles in neural differen-
tiation and/or specification (Table S2). We found that of the 29
neural differentiation factors that fulfill these criteria, 23 are
encoded by mRNAs harboring known NMD-inducing features
(Table S2), 19 of which were significantly upregulated in
response to UPF1 depletion in P19 cells (Figure 2A). At least
16 of these 19 were stabilized by NMD depletion, based on
mRNA half-life analysis in P19 cells (Figures 2B and S2A), but
note that this is a conservative estimate because this assay
does not always detect direct NMD targets (Chan et al., 2007).
To test whether this was a selective property, we next examined
whether mRNAs encoding antineural differentiation factors were
also targeted by NMD. We found that 4 of 18 factors withntiation media for the times indicated. R.Q., relative quantification.
with RA to induce differentiation were analyzed for NMD activity using the NMD
ribed in the Supplemental Experimental Procedures.
R, (E) western, and (F) immunofluorescence analyses of P19 cells transfected
RA are shown. (D) mRNA levels are relative to P19 cells not incubated with RA,
f three experiments, normalized against b-actin; error bars represent SD. (F)
); the box plot shows the distribution of protein levels in individual cells (see
ion and promote neural maturation. qPCR analysis is shown of (G) P19 cells and
tter is the negative control, which was given a value of 1). The P19 cells were
lular proliferation.
s indicated (n = 6).
rror bars represent SD.
asterisks denote statistically significant differences; p < 0.05). Unless otherwise
script levels were normalized to the level of L19 RNA for all qPCR experiments.
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Figure 2. UPF1 Promotes the Decay of mRNAs Encoding Proliferation Inhibitors and Differentiation Factors
(A) qPCR analysis of transcripts encoding the indicated classes of proteins in Upf1-depleted (siUpf1) P19 cells. The fold change of mRNA level is relative to that in
control cells treated with a siRNA against luciferase (siLuc). mRNA normalization and statistical analysis were performed as in Figure 1.
(B) RNA decay of selected mRNAs in P19 cells transfected as indicated (see Figure S2 for analysis of more mRNAs). Transcript levels were normalized to the level
of Gapdh mRNA, which is relatively stable.well-defined roles in repressing neural differentiation and/or
maturation had an NMD-inducing feature and were significantly
upregulated in UPF1-depleted cells (Figure 2A; Table S3). We
examined the half-life of two of these mRNAs, Lefty1 and
Smad1, and found that neither was stabilized upon UPF1 deple-
tion, suggesting that they are not direct NMD targets (Fig-
ure S2B). Taken together, these results provide evidence that
NMD preferentially degrades transcripts encoding neural differ-
entiation factors. This raised the possibility that NMD promotes752 Cell Reports 6, 748–764, February 27, 2014 ª2014 The Authorsthe undifferentiated cell state through this property, a possibility
we explore below.
NMD Represses Neural Differentiation by Targeting the
TGF-b Signaling Pathway
A well-established mechanism that promotes neural differentia-
tion is repression of the TGF-b/bone morphogenetic protein
(BMP) signaling pathway (Seuntjens et al., 2009). This was of in-
terest in light of our finding that several of themRNAs targeted for
decay by UPF1 in P19 cells encode TGF-b/BMP signaling
inhibitors: SMURF1, SMURF2, SMAD6, and SMAD7 (Figures 2
and S2A). These mRNAs were also upregulated in response to
UPF1 knockdown inmNSCs (Figure 3A). mNSCs lacking another
NMD factor, UPF3B, also upregulated Smad6 and Smad7
mRNA, aswell as othermRNAs (FigureS3A), providing strong ev-
idence that these are direct NMD targets. Because UPF1 targets
these mRNAs for decay and they encode negative regulators of
TGF-b/BMP signaling, this raised the possibility that UPF1 pro-
motes the TGF-b signaling pathway. In support of this hypothe-
sis, we found that UPF1 depletion inhibited TGF-b signaling, as
shown by the decreased expression of Smad2 and the TGF-b
signaling target genesCdx4andLhx1 (Liu et al., 2011) (Figure 3B).
UPF1 depletion also decreased the level of phosphorylated
SMAD2 (Figure 3C), a hallmark of TGF-b signaling (Massague´
and Xi, 2012). To further test the hypothesis that UPF1 promotes
TGF-b signaling, we prevented the downregulation of UPF1
expression that normally occurs during neural differentiation by
expressing modest levels of UPF1 from an expression vector
and found that this reduced the decrease in phospho-SMAD2
levels that normally accompanies neural differentiation (Fig-
ure S3B). Together, these data indicated that UPF1 promotes
TGF-b signaling, thereby providing a potential molecular
pathway by which UPF1 controls neural differentiation.
Because the mRNA encoding the TGF-b inhibitor, SMAD7,
was the most strongly upregulated mRNA in response to
UPF1 knockdown (Figure 2A), we deemed it a good candidate
to act in an NMD-based circuit to control neural differentiation.
In this proposed circuit, Smad7 mRNA is stabilized by NMD
downregulation, which leads to increased SMAD7 protein level
and, as a consequence, repressed TGF-b signaling, leading to
neural differentiation (Figure 3D). The existence of this NMD-
Smad7 circuit was supported by the following. First, depletion
of UPF1 increased the level of SMAD7 protein in P19 cells (Fig-
ure 3C). Second, depletion of SMAD7 in P19 cells inhibited their
ability to undergo neural differentiation (Figure 3E), consistent
with past studies that have shown that SMAD7 promotes neural
differentiation (Ozair et al., 2013). Third, several lines of evi-
dence indicated that Smad7 mRNA is directly targeted for
decay by NMD: (1) Smad7 mRNA was upregulated in response
to UPF1 depletion in both P19 cells (Figure 2A) and mNSCs (Fig-
ure 3A), (2) Smad7 mRNA was strongly stabilized by UPF1
knockdown in P19 cells (Figure 2B), (3) Smad7 mRNA was
upregulated in response to loss of the NMD factor UPF3B (Fig-
ure S3A), and (4) Smad7 possesses three putative features that
are capable of eliciting NMD (an uORF in the 50 UTR, a long 30
UTR, and an intron in the 30 UTR) (see the Introduction and
Table S2). To assess their role, we made use of a tet-regulated
vector system that allows one to identify destabilizing cis
elements by virtue of their ability to destabilize the normally
stable b-globin mRNA (Singh et al., 2008). We independently
subcloned the Smad7 50 UTR and 30 UTR upstream and
downstream, respectively, of the b-globin-coding region in this
vector and found that both greatly destabilized b-globin
mRNA, an effect that was partially reversed when Upf1
levels were depleted (Figures 3F and 3G). This verified that
Smad7mRNA is an NMD target, and it indicated that it is down-
regulated by NMD by virtue of features in both its 50 and 30 UTR.CWe performed a rescue experiment to directly address
whether Smad7 acts in a functional circuit downstream of
NMD. Using a modest dose of Smad7 small hairpin RNA
(shRNA), we largely prevented the upregulation of SMAD7
that normally occurs in response to NMD repression during
neural differentiation (Figure 3H). We found that this partially
rescued TGF-b signaling, as measured with the downstream
effectors Cdx4 and Lhx1 (Figure 3H), and largely prevented
neural differentiation, as measured with the neural markers
Nestin and Tubb3 (Figure 3I). We also tested whether overex-
pression of UPF1 had the reciprocal affect but observed no
change in Smad7 mRNA levels (Figure S3C), implying that
UPF1 is not rate limiting for NMD in P19 cells. Because there
is evidence that SMAD7 not only promotes neural differentia-
tion but also inhibits cell proliferation (Briones-Orta et al.,
2011), we also assessed whether SMAD7 has a role in
NMD’s proproliferation function. We found that knockdown of
SMAD7 did not significantly rescue the effect of NMD on
cellular proliferation in P19 cells (Figures S3D–S3F), suggesting
that NMD regulates proliferation independently of SMAD7. We
conclude that SMAD7 participates with NMD in a circuit that
specifically acts on neural differentiation, not cellular prolifera-
tion (Figure 3D).
Given that UPF1 promotes TGF-b signaling, this raised the
possibility that UPF1 might stimulate mesoderm differentiation,
which is stimulated by TGF-b signaling (Nakaya et al., 2008).
Indeed, we found that UPF1 knockdown reduced the ability of
P19 cells to differentiate down the mesoderm lineage (in
response to activin), as assessed using themesodermal markers
Brachyury (T) and Goosecoid (Gsc) (Nakaya et al., 2008) (Fig-
ure 3J). This repression of mesodermal differentiation was
reversed by preventing the upregulation of SMAD7 that normally
occurs in response to UPF1 depletion (using low-dose Smad7
shRNA; Figure 3J). Together, these data support the notion
that the UPF1/SMAD7 circuit acts through TGF-b signaling as
a binary switch to control whether precursor cells differentiate
down the neural versus mesoderm cell lineage (Figure 3D).
An NMD-miRNA Circuit that Influences Cell Fate
We previously reported that UPF1 is a direct target of miR-128, a
brain-enriched miRNA expressed in neurons in the cortex and
hippocampus in vivo whose expression is dramatically upregu-
lated during neural differentiation and maturation in vitro (Smir-
nova et al., 2005; Bak et al., 2008; Bruno et al., 2011). Coupled
with the results described above, this raised the possibility that
miR-128 serves to repress UPF1 expression in order to drive
neural precursor cells to undergo differentiation and maturation
(Figure 4A). Consistent with this possibility, miR-128 and Upf1
RNA levels are inversely expressed during neuron maturation
and differentiation in vitro and during brain development in vivo
(Figures 1A and S1A) (Bruno et al., 2011). To directly test this
hypothesis, we first performed a rescue experiment in which
we askedwhether preventing theUpf1 downregulatory response
that normally occurs when miR-128 is induced is sufficient to
block neural differentiation. Indeed, we found that, when Upf1
levels were maintained at pretreatment levels with an Upf1
expression vector, this largely inhibited miR-128-induced neural
differentiation of P19 cells (Figure S4A). Because miR-128ell Reports 6, 748–764, February 27, 2014 ª2014 The Authors 753
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promotes neural differentiation, this predicts that it would also
inhibit proliferation. Gain-of-function evidence for this was the
finding that ectopic expression of miR-128 inhibited cellular pro-
liferation and inhibited cell-cycle progression through G1/S (Fig-
ures S4B and S4C). For a loss-of-function approach, we engi-
neered a miR-128 decoy to inhibit miR-128 function
(Figure S4D). This miR-128 decoy, which inhibited P19 cells
from undergoing neural differentiation in response to RA (Fig-
ure S4E), also inhibited the blockade in cell proliferation that nor-
mally accompanies neural differentiation (Figure S4F). Rescue
experiments showed that rescuing Upf1 expression in miR-128
mimic-treated cells reversed the cell proliferation block in the
G1/S transition (Figures S4C and S4G). Taken together, these
data indicated that miR-128 (1) promotes neural differentiation;
(2) inhibits cellular proliferation at the G1/S transition; and (3)
acts, at least in part, through UPF1 to mediate these actions
(Figure 4A).
A Self-Reinforcing NMD-miRNA Feedback Control
Circuit
Our finding that UPF1 downregulation promotes neural differen-
tiation and maturation (Figures 1G and 1H) raised the possibility
that this UPF1 downregulatory response is a necessary prereq-
uisite for the dramatic induction of miR-128 expression that
occurs during neural differentiation and maturation (Bruno
et al., 2011). In other words, we hypothesized that not only
does miR-128 negatively regulate UPF1 but UPF1 also nega-
tively regulates miR-128 (Figure 4A). In support, we found that
depletion of UPF1 was sufficient to strongly induce miR-128 in
P19 cells (Figure 4B). This induction was largely prevented by
the TGF-b signaling inducer activin (Figure 4B), suggesting that
miR-128 is induced as a result of repression of TGF-b signaling.
This was further supported by the finding that incubation with the
TGF-b inhibitor, TGF-I (SB431542) (Halder et al., 2005), was
sufficient to strongly induce miR-128 expression (Figure 4B).
These data suggest the existence of a self-reinforcing negative
feedback circuit (Figure 4A; see the Discussion).
We screened other neurally expressed miRNAs to determine
whether they also target NMD factors. Figure S4I shows that
several neurally expressed miRNAs are predicted to target
NMD factors, based on using the miRNA target prediction pro-
grams MicroCosm, TargetScan, and miRanda-mirSVR. WeFigure 3. UPF1 Represses Neural Differentiation by Targeting the TGF
(A–C) UPF1 promotes TGF-b signaling.
(A) qPCR analysis of mRNAs encoding TGF-b signaling inhibitors in mNSCs trans
given a value of 1.
(B) TGF-b target genes analyzed as in (A).
(C) Western blot analysis of P19 cells treated as in (A) and quantified as in Figure
(D) Model shows that UPF1 dictates lineage-specific differentiation (Diff.) events
(E) Smad7 promotes neural differentiation. qPCR analysis is shown of P19 cells w
mRNA levels are relative to cells transfected with shRNA-C and cultured without
(F and G) Smad7mRNA is destabilized through its NMD-inducing features in the 5
with a TRE-driven b-globin reporter harboring the indicated regions of Smad7 (s
(H and I) UPF1 promotes TGF-b signaling and inhibits neural differentiation by targ
indicated siRNAs and shRNAs; mRNA levels in (I) are relative to cells transfected
(J) UPF1 promotes mesodermal differentiation by targeting Smad7 mRNA. qPCR
with the agents indicated. mRNA levels are relative to cells transfected with siLu
Quantification and statistical analysis for all data panels were done as in Figure 1
Cempirically tested the four miRNAs predicted to target the
NMD gene, UPF3B (Figure S4I), given that mutations in this
gene cause intellectual disability (Tarpey et al., 2007). We found
that three of four of these miRNAs—miR-9, miR-124, and miR-
128—repressed luciferase expression from a reporter harboring
the UPF3B 30 UTR (Figures 4C and 4D). We tested miR-9 further
because of the abundant evidence that it promotes neural differ-
entiation (Sun et al., 2013) and found that the miR-9 mimic
also downregulated endogenous UPF3B mRNA level, and a
sequence-specific miR-9 inhibitor upregulated endogenous
UPF3B protein (Figure 4E).
Given that miR-128 expression is repressed by NMD (Fig-
ure 4F), we asked whether miR-9 and miR-124 are regulated in
this manner as well. In support, we found that depletion of
UPF1 upregulated the expression of not only miR-128 but also
miR-9 and miR-124 (Figure 4G). To distinguish between these
miRNAs being regulated by UPF1 specifically or by NMD in
general, we examined the effect of loss of another NMD factor:
UPF3B. miR-9 and miR-128 were upregulated in Upf3b null
mNSCs (Figure 4G), which together with their induction in
response to depletion of UPF1 strongly suggests that they are
negatively regulated by the NMD pathway. In contrast, miR-
124 was not upregulated in Upf3b null mNSCs, suggesting that
miR-124 is either specifically regulated by UPF1 or it is regulated
by an Upf3b-independent branch of the NMD pathway (Chan
et al., 2007; Huang et al., 2011). Together, these results support
a model in which miR-128 and other neurally expressed miRNAs
participate in an NMD-driven regulatory circuit that dictates
whether a neural precursor cell remains in an undifferentiated,
proliferative state or terminally differentiates (Figure 4A).
Because NMD and the miRNAs that operate in this circuit are
mutually repressive (Figure 4F), this circuit ‘‘locks in’’ either the
undifferentiated or differentiated cell state, depending on the
input signal (see the Discussion).
Conservation of the NMD-miRNA Regulatory Circuit
We examined whether the UPF1/miR-128 regulatory circuit is
conserved in X. laevis. In support of this notion, the components
of the circuit are conserved: (1) miR-128 is identical in sequence
in X. laevis and mammals (Bruno et al., 2011); (2) the miR-128
seed-sequence complementary binding region in the 30 UTR of
X. laevis upf1 and mammalian UPF1 are identical (Bruno et al.,-b Signaling Pathway
fected with Upf1 siRNA (siUpf1) and Luc siRNA (siLuc), the latter of which was
1E.
through its ability to promote TGF-b signaling.
ith a shRNA against Smad7 (shSmad7) or a shRNA control vector (shRNA-C).
RA, which were given a value of 1.
0 and 30 UTRs. RNA half-life analysis is shown of Tet-off HeLa cells transfected
ee Supplemental Experimental Procedures for details).
eting Smad7mRNA. qPCR analysis is shown of P19 cells transfected with the
with siLuc/shRNA-C, which were given a value of 1.
analysis is shown of T and Gsc mRNA in P19 cells incubated and transfected
c/shRNA-C, which were given a value of 1.
, unless otherwise noted. See also Figure S3.
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Figure 4. A Posttranscriptional Circuit that Influences Differentiation versus Proliferation Decisions
(A) Model shows miR-128 and UPF1 opposing each other in a circuit that controls neural differentiation and proliferation.
(B) TaqMan-qPCR analysis of miR-128 levels in P19 cells, normalized against U6 snRNA. miR-128 levels are relative to cells treated with the negative control,
EtOH/siLuc, which had a background PCR signal (not detectable [N.D.]) that was assigned a value of ‘‘1’’ to provide a conservative estimate of miR-128 induction
in response to the other treatments.
(C) Conservation of putative miRNA target sites in the Upf3b 30 UTR. Has, Homo sapiens; Mmu,Mus musculus; Ptr, Pan troglodytes; Mml,Macaca mulatta; Ocu,
Oryctolagus cuniculus; Gga, Gallus gallus; Xtr, Xenopus tropicalis.
(D) Luciferase expression from the pMiR-Luc-3B reporter harboring the full-lengthUpf3b 30 UTR cotransfected into HeLa cells with the indicatedmiRNAmimic or
the negative control mimic (miR-C).
(E) Left view shows qPCR analysis of HeLa cells transfected as indicated. Middle and right views present western blot analysis of P19 cells with a miR-9 inhibitor
(miR-9 inh) or negative control inhibitor (miR-C Inh), quantified as in Figure 1E.
(F) Model shows NMD and neurally expressed miRNAs mutually suppressing each other, which serves to lock in a given cell state.
(G) Repression of NMD induces NMD inhibitory miRNAs. TaqMan-qPCR analysis is shown of mNSCs (wild-type [WT] on the left; WT and Upf3b null on the right)
transfected with the indicated siRNAs and miRNA mimics.
Quantification and statistical analysis of all data panels were done as in Figure 1, unless otherwise noted. See also Figure S4.
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2011); and (3) the UPF1 protein sequence is >90% identical in
Xenopus and mammals (Figure S5A). In further support, we
found that upf1 mRNA level decreases during the development
of the X. laevis presumptive neural tissue (the anterior ectoderm
region) in a pattern inversely correlated with the induction ofmiR-
128 (Bruno et al., 2011), just as Upf1 mRNA levels do during
mouse brain development (Figures S5B and S5C). This decrease
in upf1 mRNA levels coincides with an increase in all the direct
NMD target transcripts that we examined—atf3, axin2, dkk1,
smad7, and cdkn1a—during both X. laevis and mouse neural
development (Figures S5B and S5C; data not shown). Coupled
with our previous finding that ectopic expression of miR-128 in
X. laevis embryos downregulates NMD, as judged by assessing
X. laevis NMD target transcripts (Bruno et al., 2011), these data
strongly suggest that the UPF1/miR-128 circuit is conserved
and regulated during anterior ectoderm embryonic development
in X. laevis.
To assess whether themagnitude of NMD is depressed during
X. laevis neural development, we turned to an in vitro system in
which the mRNA encoding the neural inducer Noggin (a potent
TGF-b/BMP inhibitor) is microinjected into the animal pole region
of two-cell embryos topromote their differentiation intoneural tis-
sue when isolated at the late blastula stage and cultured in vitro
(Lamb et al., 1993). We found that Noggin treatment dramatically
reduced Upf1mRNA levels and increased the levels of the direct
NMDtarget transcriptsatf3,axin2,smad7, andcdkn1a (Figure5A;
data not shown), thereby recapitulating the molecular events
occurring during the in vivodevelopment of theanterior ectoderm
region (Figures S5B and S5C) and providing evidence that the
magnitude of NMD is repressed during X. laevis neural develop-
ment. To examine the specificity of this response, we injected
the mRNA encoding constitutively activated BMP receptor
(CABR), which has the opposite effect: it promotes epidermal
differentiation and represses neural differentiation (Suzuki et al.,
1997). As expected, this treatment induced BMP-responsive
genes and the epidermal differentiation marker keratin, but not
neural markers (Figure 5B). Interestingly,Upf1mRNA expression
was strongly upregulated by this epidermal differentiation proto-
col (Figure 5B), indicating that epidermal differentiation induces
the opposite upf1 response as compared to neural differentiation
(Figure 5A). miR-128 expression was reduced under epidermal
differentiation conditions (Figure S5D), providing further evi-
dence for an opposite response.Weconclude that the repression
of NMD is a conserved and specific response that occurs during
neural development.
To assess the functional relevance of this NMD downregula-
tory response, we manipulated Upf1 levels in X. laevis embryos.
First, we inhibited Upf1 expression by injecting two-cell embryos
with a morpholino (MO) complementary with the translation initi-
ation region of upf1mRNA (Figure 5C). Consistent with the ability
of MOs to only block translation, the Upf1 MO decreased Upf1
protein level, not upf1 mRNA level (Figures 5D and S5E), which
led to reduced NMD magnitude, based on the upregulation of
two NMD target transcripts we tested: axin2 and smad7 (Fig-
ure 5D). The upf1 MO also increased the expression of neural
markers (Figure 5D), providing evidence that downregulation of
Upf1 is sufficient to initiate the early stages of neural differentia-
tion in X. laevis, just as we showed it does in mammalian cellsC(Figures 1G and 1H). Although X. laevis embryos treated with
the upf1 MO were viable in early stages, at the late gastrula
stage, they exhibited dose-dependent lethality (Table S4).
Lethality at the gastrula stage was also elicited by modest
overexpression of UPF1 (Table S4). Together, these results
suggested that whereas the Upf1 downregulatory response
promotes X. laevis neural differentiation, its expression must
be fine-tuned to allow for the survival and development of early
X. laevis embryos.
To investigate whether the UPF1 downregulatory response
that occurs during X. laevis presumptive neural tissue develop-
ment (Figure S5C) promotes neural differentiation just as it
does in mammalian cells (Figures 1G and 1H), we elected to
use a strategy that interferes with the ability of neurally induced
miR-128 to downregulate UPF1. Thus, we designed two overlap-
ping MOs that compete with miR-128 for binding to the upf1 30
UTR (Figure 5C). These upf1 target protectors (TPs) blocked
the ability of miR-128 to regulate an artificial miR-128 target
substrate, pLmiR-xU3m, but not a mutant version with a debili-
tated miR-128-binding site (Figure 5E). We next examined
whether the upf1 TPs inhibited the downregulation of UPF1
that normally occurs during X. laevis development and found
that, indeed, both TPs increased upf1 mRNA and Upf1 protein
levels in the anterior ectoderm region of stage 19 embryos
(Figure 5F; data not shown).
The ability of the upf1 TPs to prevent the downregulation of
Upf1 that normally occurs during neural development allowed
us to ask whether this Upf1 downregulatory response has
the same role in neural maturation and proliferation in
X. laevis embryonic development as it does in mammalian neu-
ral cells. We found that both upf1 TPs reduced the expression
of neural markers, and both upregulated proliferation markers
(Figure 5G), providing molecular evidence that the downregula-
tion of UPF1 is required for terminating proliferation and
inducing neuronal differentiation during neural development.
To morphologically evaluate the effect of UPF1 modulation,
we performed unilateral injections in two cells at the four-cell
embryo stage. As shown in Figure 6A, injection of the upf1
TP elicited increased Upf1 protein expression in the side in-
jected, as demonstrated by immunohistochemical analysis
(particularly evident in the anterior region). Consistent with
our finding that Upf1 promotes proliferation in mammalian cells
(Figures 1I–1L and S1H), we found that the side injected with
the upf1 TP exhibited tissue expansion (Figure 6A). This was
likely the result of increased cellular proliferation, based on
finding a considerably wider band of bromodeoxyuridine
(BrdU) labeling on the upf1 TP-injected side relative to the con-
trol side (Figure 6B). The upf1 TP-injected side exhibited
considerable cell proliferation in all epidermal regions, whereas
the uninjected side only exhibited high proliferation in the
anterior and neural fold edge areas. The upf1 TP-injected
side also exhibited repressed formation of neural tissues,
including complete absence of lens and cement gland in
the anterior region of embryos, as judged by whole-mount
immunostaining with the neural marker Ncam (Figures 6C
and 6D). As further evidence of repressed neural differentiation,
immunofluorescence analysis showed that the particular re-
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to upf1 TP injection were the regions with decreased neural
differentiation, as judged by Ncam staining (Figure 6E).
Reduced Ncam staining was most prominent in the dorsal re-
gion of the neural tube (Figure 6E).
As a reciprocal test, we examined whether depressing UPF1
levels caused the converse effect: decreased cell proliferation
and increased neural differentiation. Indeed, we found that the
upf1 MO triggered tissue shrinkage on the injected side (Fig-
ure 6F), consistent with decreased proliferation, and it increased
Ncam staining, particularly in the regions with decreased Upf1
staining, such as the posterior region of the spinal cord (Fig-
ure 6G). The upf1 MO also reduced the size of the spinal cord
and disrupted the organization of the neural tissue, which
normally form stacked, tightly patterned structures (Figure 6G).
Taken together, these results indicated that Upf1 has a
conserved role in promoting cellular proliferation and that its
downregulation is required for X. laevis neural cells to exit the
cell cycle and undergo differentiation.
DISCUSSION
The nature of the mechanisms underlying the decision whether
an immature cell remains in an undifferentiated, proliferative cell
state or commits to the postmitotic differentiated cell state is an
intriguing biological problem. In this paper, we provide evidence
that this decision is controlled by an elaborate posttranscrip-
tional circuit revolving around the NMD pathway (Figure 7). In
particular, our results support the notion that the undifferenti-
ated, stem-like cell state is stabilized by NMD’s propensity
to rapidly degrade mRNAs encoding prodifferentiation factors
and proliferation inhibitors transcribed from genes not fully
repressed by transcriptional mechanisms (Figures 2 and S2).
In response to neural differentiation signals, NMD is downregu-
lated (Figures 1A–1C and S1A–S1C), which stabilizes these
mRNAs, allowing for neural differentiation (Figures 2B and
S2A). In support of this model, we found that preventing the
downregulation of the key NMD factor, UPF1, inhibited neural
differentiation and maintained the proliferative state (Figures
1D–1F, 1K, and 1L). Furthermore, knockdown of UPF1 using
RNAi was sufficient to trigger neural differentiation, promote
neural maturation, and inhibit the proliferation of pluripotent
cells (Figures 1G and 1H). Together, our results strongly sug-
gest that NMD is a crucial posttranscriptional mechanism
controlling the switch between the pluripotent and differentiated
cell states.Figure 5. Conservation of the UPF1-miR-128 Regulatory Circuit
(A and B) qPCR analysis is shown of isolated X. laevis ectoderm tissue derived f
epidermal differentiation, respectively. b-galactosidase mRNA serves as the in
epidermal (Epi) marker. The muscle (m)-actin mesoderm marker is not detectabl
(C–G) Evidence that miR-128 drives X. laevis neural differentiation by repressing
(C) Diagram depicting the TP MOs that prevent miR-128 binding to the UPF1 30
(D) qPCR analysis of isolated ectodermal tissue derived from embryos injected w
(E) Luciferase analysis of embryos injected with the indicated molecules and cul
(F) Western blot analysis of isolated X. laevis ectoderm tissues derived from em
against b-actin).
(G) qPCR analysis of isolated X. laevis ectoderm tissues treated as in (F).
(H) Model shows conservation of the UPF1-miR-128 regulatory circuit.
Quantification and statistical analysis of all data panels were performed as in Fig
COur finding that NMD acts through the TGF-b signaling
pathway to maintain the undifferentiated cell state (Figure 3)
mechanistically connects the well-studied TGF-b signaling
pathway with a posttranscriptional mechanism. Given the wealth
of evidence that a blockade of TGF-b signaling is required for
neural differentiation (Watabe and Miyazono, 2009), our dis-
covery that NMD strongly promotes TGF-b signaling provides
a mechanism by which NMD blocks neural differentiation.
In particular, we found that the NMD downregulatory response
triggered by neural differentiation cues causes stabilization of
Smad7 mRNA, which, in turn, leads to increased levels of
SMAD7 protein, inhibited TGF-b signaling, and, consequently,
the induction of neural differentiation (Figures 3, S3A, and
S3B). The discovery of this NMD circuit is important because
it had not previously been clear whether the ability of NMD to
alter the levels of normal transcripts is physiologically significant.
The many defects that have been described occurring in
NMD-deficient organisms (Vicente-Crespo and Palacios, 2010)
could, in principal, be entirely the result of toxicity emanating
from the expression of abnormal proteins translated from
aberrant PTC-containing mRNAs (e.g., generated by alternative
splicing) that would accumulate if NMD were not functioning
(Chang et al., 2007; Nicholson et al., 2012). Complementing
our discovery of an NMD circuit that operates in mammals, it
was recently shown that the ability of NMD to destabilize the
mRNA encoding the copper transporter CTR2 is responsible
for increasing the sensitivity of Saccharomyces cerevisiae to
copper toxicity (Wang et al., 2013b).
Another nonmutually exclusive mechanism by which NMD
may promote the undifferentiated cell state is by stimulating
cell proliferation. Indeed, our loss-of-function studies per-
formed in both mouse cell lines and X. laevis embryos indi-
cated that UPF1 is required for normal cell growth (Figures
1I–1L, S1H, 6A, 6B, 6D, and 6F). This is consistent with previ-
ous loss-of-function studies that obtained evidence that NMD
promotes cell proliferation (Avery et al., 2011; Weischenfeldt
et al., 2008). Interestingly, studies have differed as to the phase
of the cell cycle that they assign as being targeted by NMD.
D. melanogaster cell lines depleted of various NMD factors
were shown to be arrested at the G2/M phase of the cell cycle
(Rehwinkel et al., 2005), depletion of UPF1 was found to inhibit
the growth of HeLa cells at S phase (Azzalin and Lingner,
2006), and we found that depletion of UPF1 in P19 cells
inhibited G1/S progression (Figures 1L and S1H). Although
the data from these loss-of-function studies support the notionrom embryos injected with noggin (nog) and cabr mRNA to induce neural and
jection control. smad7 and axin2 are NMD target transcripts. Keratin is an
e (N.D.), indicating no mesodermal tissue contamination.
UPF1 levels.
UTR and the upf1 MO that blocks UPF1 translation.
ith the MOs indicated.
tured until stage (st) 12 (TP-C is a negative control TP MO).
bryos injected with the indicated MOs (five embryos per samples, normalized
ure 1. See also Figure S5 and Table S4.
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Figure 6. The UPF1/miR-128 Circuit Controls X. laevis Cell Proliferation and Differentiation
(A and B) miR-128 inhibits X. laevis cellular proliferation by repressing UPF1.
(A) Stage 33 embryos stained for UPF1 expression (brown) unilaterally injected with a MO blocking miR-128 binding to the upf1 30 UTR (TP-1; see Figure 5C). The
TP-1-injected side had elevated UPF1 levels andmore extensive tissue expansion (white arrowhead) than the noninjected side (similar results were obtained with
TP-II; data not shown).
(B) BrdU labeling of embryos unilaterally injected as in (A) (red denotes BrdU-labeled cells). Increased cell proliferation was observed on the TP-II-injected side.
(C–E) miR-128 promotes X. laevis neural differentiation by repressing UPF1.
(C) Diagram of embryo injected with upf1 TPs.
(legend continued on next page)
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Figure 7. Model of a Posttranscriptional Switch that Controls Neural
Stem Cell Fate
UPF1 promotes the undifferentiated, proliferative cell state by promoting the
decay of mRNAs encoding proneural differentiation factors (including inhibi-
tory SMADs [I-SMADS]) and G1/S proliferation inhibitors). This stem-like state
is reinforced by the ability of UPF1 to repress the expression of the proneural
differentiation miRNA, miR-128. Neural differentiation and cessation of cell
growth are triggered by signals that either repress NMD or induce miR-128
because both lead to repressed TGF-b signaling and elevated levels of neural
differentiation/proliferation inhibitor molecules. Reinforcing the switch to the
differentiated cell state is the elevated levels of miR-128 resulting from
repressed TGF-b signaling.that NMD promotes proliferation, an alternative possibility is
that loss of NMD causes general toxicity, leading to depressed
proliferation merely as a downstream consequence. We ob-
tained two lines of evidence supporting a role for UPF1 in pro-
liferation, rather than merely being required for cell survival.
First, our gain-of-function studies showed that modest over-
expression of UPF1 increased cellular proliferation in both
mouse P19 cells and X. laevis embryos (Figures 1J–1L, S1H,
6A, and 6B). Second, we showed that NMD selectively de-
creases the levels of mRNAs encoding proliferation inhibitor
proteins, many of which are likely to be direct NMD targets
(Figures 2 and S2). This suggested that NMD not only pro-
motes proliferation, but it does so by acting directly on prolif-
eration regulators.
We demonstrated that depletion of the NMD factor UPF1 was
sufficient to both inhibit proliferation and trigger cellular neural
differentiation in both mouse cells in vitro and X. laevis embryos
in vivo (Figures 1G–1I, 1L, 5D, 6F, 6G, and S1H). This suggests
that the UPF1 downregulatory response that normally occurs
during neural development is a critical rate-limiting step for
neural differentiation (Figures 1A and S1A). Recently, another
case in which withdrawal of a single factor triggers neural differ-
entiation was reported: knockdown of the RNA-binding protein,
PTB, was shown to reprogram differentiated nonneuronal cells
into neurons (Xue et al., 2013). Interestingly, we identified other
NMD factors—in addition to UPF1—that are downregulated(D) Stage 33 (left) and stage 25 (right) embryos unilaterally injected and stained fo
greater Upf1 expression/tissue growth (yellow asterisks) and lower Ncam expres
(E) Dorsal-ventral cross-section of a stage 25 embryo unilaterally injected and st
(F and G) Upf1 promotes neural proliferation.
(F) Stage 25 (left) and stage 28 (right) embryos unilaterally injected at the four-cell s
upf1 MO-injected side had lower UPF1 expression (white arrowheads) and failed
(G) Anterior-posterior cross-section of a stage 28 embryo unilaterally injected and
had lower Upf1 expression, higher Ncam expression, and disorganized neural tis
An., anterior; b., brain; c.g., cement gland; n.f., neural fold; n.t., neural tube; o.c.
Cduring neural maturation (Figure 1A), raising the possibility
that their downregulation may also contribute to neural devel-
opment. However, we do not know whether these other factors
are rate limiting for NMD in neural stem or progenitor cells.
Indeed, a previous study showed that most NMD factors are
not rate limiting for NMD in HeLa cells (Huang et al., 2011).
Another consideration is that NMD is a branched pathway,
each branch of which degrades different sets of mRNA sub-
strates. Two of the NMD factors that we found were downregu-
lated during neural maturation—UPF2 and UPF3B (Figure 1A)—
are required for specific branches of the NMD pathway
(Gehring et al., 2005; Chan et al., 2007; Huang et al., 2011).
Thus, the downregulation of these two NMD factors during neu-
ral maturation would be predicted to lead to stabilization of only
a specific subset of NMD target mRNAs (assuming that UPF2
and UPF3B are rate limiting for NMD in neural precursor cells).
Finally, we note that some NMD factors may have complex
roles in which they promote some developmental steps and
inhibit others. As a case in point, depletion of UPF3B was
recently shown to inhibit the differentiation of neural progenitor
cells (Jolly et al., 2013), whereas we obtained evidence that loss
of UPF3B promotes the early differentiation of neural stem cells
(Figure S1G). In the future, it will be important to determine
whether modulation of specific NMD factors has clinical appli-
cations. Given that mutations in UPF3B—a gene essential for
a branch of NMD—cause intellectual disability and are strongly
associated with schizophrenia and autism in humans (Tarpey
et al., 2007), this raises the possibility that modulation of the
UPF3B-dependent branch of NMD could benefit patients with
brain disorders.
We demonstrated that UPF1 functions in a conserved circuit
with the miRNA, miR-128, in determining whether a cell prolifer-
ates or differentiates (Figures 4, 5, and 6). A unique layer of regu-
lation that we uncovered within this miR-128/UPF1 circuit is a
negative feedback loop that we suggest stabilizes the output
of the circuit. We found that UPF1 strongly represses miR-128
expression (Figures 4B and 4G), which coupled with the ability
of miR-128 to repress UPF1 expression, creates mutually rein-
forcing negative feedback loops that would be predicted to
form a bistable circuit (Figures 4A and 4F). In an undifferentiated
cell, NMD is high, leading to suppressed miR-128 expression,
which in turn perpetuates a high magnitude of NMD, thereby
maintaining a stable undifferentiated cell state. In response to
a neural differentiation signal that represses NMD, miR-128 is
induced, which in turn further decreases the magnitude of
NMD and reinforces miR-128 expression, thereby stabilizing
the differentiated cell state. This circuitry also allows versatility
because a neural differentiation signal whose primary action is
to induce miR-128 rather than downregulate NMD (e.g., throughr Ncam (red) and Upf1 (brown) expression. The side injected with upf1 TPs had
sion (yellow arrowheads) than the noninjected side.
ained for Upf1 (green) and Ncam (red) expression.
tage with the upf1MO (Figure 5C) and stained for Upf1 expression (brown). The
to expand (red asterisks) as much as the noninjected side.
stained for Upf1 (green) and Ncam (red) expression. The upf1MO-injected side
sue (white arrowhead).
, optical cup; Po.: posterior; s.c., spinal cord.
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repressed TGF-b signaling; Figure 4A) would lead to the same
outcome. We propose that this circuitry is reinforced by two
other neurally expressed miRNAs: miR-9 and miR-124. We
obtained evidence that, like miR-128, these twomiRNAs repress
the expression of NMD factors and are induced in response
to repressed NMD (Figures 4C–4E and 4G). In addition, both
these miRNAs are primarily expressed in the nervous system,
and there is evidence that both regulate neural development
(Sun et al., 2013; Krichevsky et al., 2006). Another miRNA that
may contribute to this regulation is miR-125, a neurally ex-
pressed miRNA that was recently shown to repress the expres-
sion of the NMD factor SMG1 (Wang et al., 2013a) and promote
the early neural specification of human embryonic stem cells
(Boissart et al., 2013). Thus, there is a growing constellation of
miRNAs that are candidates to collaborate with miR-128 to
repress NMD in neural precursor cells and thereby drive their
differentiation.
In conclusion, our results support a model in which a
conserved posttranscriptional circuit comprised of neural
differentiation-inducing miRNAs, the TGF-b signaling pathway,
and an RNA decay mechanism with selectivity for specific
mRNAs serves to help dictate the balance between stemness
and differentiation. In the absence of any input, this circuit
locks in the undifferentiated, proliferative cellular state. In
response to neural differentiation signals, this circuit switches
to a differentiation mode by stabilizing mRNAs that promote
the nonproliferative, differentiated cell state. It will be of future
interest to identify the nature of the input signals that switch
this circuit between its two modes and whether approaches
can be developed to modulate this circuit for the purposes of
regenerative medicine.
EXPERIMENTAL PROCEDURES
Mammalian Cell Culture and Transfection
P19 cells were transiently transfected with Lipofectamine 2000 (Invitrogen).
Unless otherwise noted, they were differentiated 8 hr after transfection by
culturing in the presence of RA (5 3 107 M) for 3 days. Primary mNSCs
were isolated from embryonic day 14.5 (E14.5) mouse brains and grown as
neurospheres. They were differentiated by withdrawing the hormones, as
described by Bruno et al. (2011) and Yuan et al. (2011).
RNA, Luciferase, Protein Analysis, and Vectors
Total cellular RNA was isolated as described by Chan et al. (2007). qPCR
analysis was done in triplicate as described by Chan et al. (2007). TaqMan
qPCR was performed with the TaqMan miRNA assay (Applied Biosystems).
NMD activity was measured using the NMD reporter plasmids pCI-NEO-WT
PTC () and pCI-NEO-NS39 PTC (+), which both express Renilla luciferase
(Boelz et al., 2006). They were cotransfected with pCI-NEO-FLY, a Firefly
luciferase control plasmid, two times within a 24 hr interval in P19 cells. To
measure NMD activity using the tet promoter-based NMD reporters b-PTC
(+) or b-PTC () (Singh et al., 2008), these plasmids were cotransfected
into P19 cells with pTet.tTAK, which expresses the TRE activator tTA. The
cells were incubated with doxycycline (which blocks tTA activity) for the
times shown 3 days after treatment with RA or the diluent (EtOH) alone.
The cells were treated with RA (5 3 107 M) 8 hr after the second transfec-
tion. To determine the RNA half-life of endogenous mRNAs, P19 cells were
treated with actinomycin D (5 mg/ml) 48 hr after transfection. To determine
the effect of cloned mRNA sequences on RNA stability, we used a tet pro-
moter-based NMD reporter system previously described in Yamashita and
Ohno (2010). Western blot analysis was performed as described by Chan
et al. (2007). Immunofluorescence analysis of P19 cells was performed762 Cell Reports 6, 748–764, February 27, 2014 ª2014 The Authorsfollowing the Cell Signaling Technology protocol. Microscopic analysis and
quantification of colocalized protein intensity were calculated using the Leica
Acquire software (LAS) Colocalization AF6000. Vectors are described in the
Supplemental Experimental Procedures. All primer sequences are provided
in Table S5.
Identification of NMD-Inducing Features
The following criteria were used to identify transcripts with NMD-inducing
features from the Ensembl database: (1) uORF defined by an ATG start site
that encodes at least ten amino acids; (2) a 30 UTR at least 0.7 kb in length
(based on the finding that >0.5 kb 30 UTR can trigger NMD [Singh et al.,
2008]); and (3) an in-frame stop codon >55 nt upstream of the last exon-
exon junction. We only considered transcripts defined as full length in the data-
base, e.g., those with an initiator ATG, valid stop codon, no frameshifts within
the main reading frame, and consensus splice sites.
Cell-Cycle and Cell-Count Analyses
For cell-count analysis, cell counts were made with trypan blue using a
hemocytometer. For cell-cycle analysis, cells were stained with propidium
iodide and analyzed by flow cytometry.
X. laevis Procedures
The preparation of X. laevis embryos, their microinjection, and their culturewas
performed as described by Uzgare et al. (1998). Whole-embryo injections were
performed at the two-cell stage. Unilateral injections were performed in two
cells at the four-cell stage. BrdU labeling was performed following the Abcam
BrdU-labeling kit protocol. Whole-mount staining was performed as described
by Becker and Gard (2006).
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
five figures, and five tables and can be found with this article online at http://
dx.doi.org/10.1016/j.celrep.2014.01.028.
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